With Shanghai listing done, Chinese biotech firm readies Hong Kong IPO


WuXi AppTec, the mainland's leading biotechnology firm, has announced a plan to sell shares in Hong Kong, just two months after it went public in Shanghai via a fast-tracked listing. The board has approved a plan for a listing on the main board of the Hong Kong stock exchange, and the new shares will account for 10 per cent to 15 per cent of its enlarged share total, the company said in a filing to the Shanghai Stock Exchange on Sunday.



from Biotech News